Since it has been reported that Aβ early soluble forms anomalously increase activity-regulated cytoskeleton-associated protein (Arc) levels in AD patients and animal models [19], we also analyzed its mRNA expression as a positive control to validate our results. Here, ARC is linked to Alzheimer disease.